BioCryst prices stock offering at $9.75 per share
BioCryst
Related Blog Posts
- Delay in H1N1 vaccine production could boost BioCryst
- Durham firm develops intravenous H1N1 vaccine
- Pharmaceutical firm with lab in Durham wins $77.2M federal contract for flu drug development
On The Web
Site Search
Get the latest news alerts: Follow LTW at Twitter
Associated Press
BIRMINGHAM, Ala. — Flu-drug developer BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX) priced its 5 million common stock share offering at $9.75 per share.
BioCryst has a lab in Durham, N.C.
On Thursday after the markets closed, the company estimated gross proceeds of $48.8 million. The banks underwriting its offer will have the option to buy another 750,000 shares to cover over-allotments in the following month. If all 5.75 million shares are sold, BioCryst's share count will rise almost 15 percent.
BioCryst's most advanced drug candidate is peramivir, a flu drug intended to be given by IV to patients who are too sick to take an oral dose. Peramivir has been approved as an emergency treatment for swine flu, but clinical testing against seasonal flu is expected to last until 2011.
Shares of the company fell 69 cents, or 6.6 percent, to $9.71 in morning trading.
Copyright 2010 by The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Featured
Hot Off The Wire
- Update: Hot Off the Wire – Google slashes Nexus One termination fee; MySpace Music tunes up audio ads; Barry Diller’s IAC beats Street
- Hot Off the Wire – Man convicted in first economic espionage case; iPhone market share grows; Electronic Arts shares falter after revenue forecast; Phone company wants to charge Google
- FairPoint looks to cut debt by two thirds with bankruptcy plan
E-mail Preferences
The Skinny
- Gears of War 3 coming? EA discloses Epic game for 2011
- Nagoya University bridges East, West with Nu Tech event
- E-mail services provider iContact investigating a hack attack
- Cyberespionage? Cyberslueths disclose Lenovo’s 2010 ‘roadmap’
- Tech recovery is at hand, analysts tells N.C. IT execs
- Believe it - Triangle region lands record $1.9B in business projects
- Epic Games’ heroes take their guns to a new world – ‘Lost Planet 2’
- IPO rewards: Motricity CEO gets a $75,000 raise in new contract
- IT recession over? Spending will rebound, analysis firm says
- Google vs. the Dragon – War over words could ignite into flames